top of page

Recent Publications

 

Ren Boyu, Lipsitz Stuart R, Weiss Roger D, Fitzmaurice Garrett M. Methods for handling missing binary data in substance use disorder trials. Drug Alcohol Depend. 2023 Sep 1;250:110897. doi: 10.1016/j.drugalcdep.2023.110897. Epub 2023 Jul 13. PMID: 37544038.

 

Paschen-Wolff M, Greenfield SF, Kathryn McHugh R, Burlew K, Pavlicova M, Choo TH, Barbosa-Leiker C, Ruglass LM, Mennenga S, Rotrosen J, Nunes EV, Campbell ANC. Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder. Am J Addict. 2023 Aug 15. doi: 10.1111/ajad.13463. Epub ahead of print. PMID: 37583120.

Cowan E, Perrone J, Bernstein SL, Coupet E Jr, Fiellin DA, Hawk K, Herring A, Huntley K, McCormack R, Venkatesh A, D'Onofrio G. National Institute on Drug Abuse Clinical Trials Network Meeting Report: Advancing Emergency Department Initiation of Buprenorphine for Opioid Use Disorder. Ann Emerg Med. 2023 Sep;82(3):326-335. doi: 10.1016/j.annemergmed.2023.03.025. Epub 2023 May 12.PMID: 37178101

 

McCormack RP, Rotrosen J, Gauthier P, D'Onofrio G, Fiellin DA, Marsch LA, Novo P, Liu D, Edelman EJ, Farkas S, Matthews AG, Mulatya C, Salazar D, Wolff J, Knight R, Goodman W, Williams J, Hawk K.Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled TrialAnn Emerg Med. 2023 Sep;82(3):272-287. doi: 10.1016/j.annemergmed.2023.02.013. Epub 2023 May 2.PMID: 37140493

Karnik NS, Marsden J, McCluskey C, Boley RA, Bradley KA, Campbell CI, Curtis ME, Fiellin D, Ghitza U, Hefner K, Hser YI, McHugh RK,  McPherson SM, Mooney LJ, Moran LM, Murphy SM, Schwartz RP, Shmueli-Blumberg D, Shulman M, Stephens KA, Watkins KE, Weiss  RD, Wu LT.  The opioid use disorder core outcomes set (OUD-COS) for treatment research: findings from a Delphi consensus study. Addiction. 2022 Sep;117(9):2438-2447. doi: 10.1111/add.15875. Epub 2022 Apr 25. PMID: 35293064; PMCID: PMC9543602. https://pubmed.ncbi.nlm.nih.gov/35293064/

D’Onofrio G, Hawk KF, Perrone J, et al. Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl. JAMA Netw Open. 2023;6(3):e236108. doi:10.1001/jamanetworkopen.2023.6108 

Kropp FB, Smid MC, Lofwall MR, Wachman EM, Martin PR, Murphy SM, Wilder CM, Winhusen TJ. Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study. J Subst Use Addict Treat. 2023 Apr 4;149:209030. doi: 10.1016/j.josat.2023.209030. Epub ahead of print. PMID: 37023858. https://pubmed.ncbi.nlm.nih.gov/37023858/

Protocol publications (select each protocol)

Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION)

Sub Study: Emergency Department-INitiated bupreNOrphine and VAlidaTIOn Network Trial (ED-INNOVATION)

bottom of page